UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056191
Receipt number R000063485
Scientific Title An Open-Label, Randomized Parallel-Group Non-Inferiority Trial Comparing the Efficacy and Safety of Implantation with Continuous Pacing Stimulation in Left Bundle Branch Area Pacing to Conventional Therapy.
Date of disclosure of the study information 2024/11/19
Last modified on 2026/01/07 07:30:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An Open-Label, Randomized Parallel-Group Non-Inferiority Trial Comparing the Efficacy and Safety of Implantation with Continuous Pacing Stimulation in Left Bundle Branch Area Pacing to Conventional Therapy.

Acronym

An Open-Label, Randomized Parallel-Group Non-Inferiority Trial Comparing the Efficacy and Safety of Implantation with Continuous Pacing Stimulation in Left Bundle Branch Area Pacing to Conventional Therapy.

Scientific Title

An Open-Label, Randomized Parallel-Group Non-Inferiority Trial Comparing the Efficacy and Safety of Implantation with Continuous Pacing Stimulation in Left Bundle Branch Area Pacing to Conventional Therapy.

Scientific Title:Acronym

An Open-Label, Randomized Parallel-Group Non-Inferiority Trial Comparing the Efficacy and Safety of Implantation with Continuous Pacing Stimulation in Left Bundle Branch Area Pacing to Conventional Therapy.

Region

Japan


Condition

Condition

Atrioventricular block

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to compare the efficacy and safety between novel method with contenuous pacing using a stylet-driven lead and intermittent pacing using a lumenless lead.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Acute procedure success: Percentage of patients achieving sucsessful left bandle branch area pacing.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Intervention group: contenuous pacig method using a stylet-driven lead
Intervention duration: during pacemaker implantation
Number of interventions: once
Frequency: once

Interventions/Control_2

Control group: conventional method using a lumenless lead
Intervention duration: during pacemaker implantation
Number of interventions: once
Frequency: once

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients are eligible for this study if they meet the following criteria.
1) Patients are older than 18 years.
2) Patients who required frequent ventricular pacing (>20%) due to bradyarrhythmia (atrioventricular block, bifascicular or trifascicular block, bradycardic atrial fibrillation).

Key exclusion criteria

1) Patients who are not expected to have a ventricular pacing burden of > 20%.
2) Patients who are eligible for an implantable cardioverter defibrillator (ICD) or a cardioverter defibrillator with biventricular pacing function (CRT-D).
3) Patients who have difficulty with transvenous lead placement.
4) Patients who are allergic to contrast.
5) Patinets who are pregnant or may become pregnant, or who are breast-feeding.
6) Patients who are considererd inappropriate by the principal investigator.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Yousaku
Middle name
Last name Ookubo

Organization

Hiroshima University Hospital

Division name

Cardiology

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima Prefecture

TEL

082-257-5540

Email

yokubo@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Junji
Middle name
Last name Maeda

Organization

Hiroshima University Hospital

Division name

Cardiology

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima Prefecture

TEL

082-257-5540

Homepage URL


Email

jun2.shiningcrystal@gmail.com


Sponsor or person

Institute

Other

Institute

Department

Personal name



Funding Source

Organization

Other

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hiroshima University Hospital

Address

1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima Prefecture

Tel

082-257-5540

Email

-


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 11 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 09 Month 30 Day

Date of IRB

2024 Year 09 Month 27 Day

Anticipated trial start date

2024 Year 11 Month 19 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 11 Month 19 Day

Last modified on

2026 Year 01 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063485